Literature DB >> 26347350

["Expanded prostate cancer index composite" (EPIC-26): Results of functional treatment in patients with localized prostate cancer].

B Beyer1, H Huland2, G Feick3, M Graefen2.   

Abstract

The standardized collation of the quality of treatment is a subject of discussion both nationally and internationally. This article presents the work of the International Consortium for Health Outcomes Measurement (ICHOM) and the validated German translation of the expanded prostate cancer index composite (EPIC-26). This questionnaire allows a standardized interdisciplinary collation of the quality of treatment for all therapy modalities of localized prostate cancer. Use of the ICHOM standard set and the EPIC-26 achieves a possibility for comparison of each form of therapy with respect to the curative success and the effect on health and quality of life of patients.

Entities:  

Keywords:  Disease symptoms; Quality of life; Scoring system; Treatment quality; Treatment strategies

Mesh:

Year:  2015        PMID: 26347350     DOI: 10.1007/s00120-015-3922-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  4 in total

1.  A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.

Authors:  Lionne D F Venderbos; Roderick C N van den Bergh; Monique J Roobol; Fritz H Schröder; Marie-Louise Essink-Bot; Chris H Bangma; Ewout W Steyerberg; Ida J Korfage
Journal:  Psychooncology       Date:  2014-08-20       Impact factor: 3.894

2.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Authors:  J T Wei; R L Dunn; M S Litwin; H M Sandler; M G Sanda
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

3.  Quality of life and satisfaction with outcome among prostate-cancer survivors.

Authors:  Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

4.  An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.

Authors:  George van Andel; Andrew Bottomley; Sophie D Fosså; Fabio Efficace; Corneel Coens; Stephane Guerif; Howard Kynaston; Paolo Gontero; George Thalmann; Atif Akdas; Sven D'Haese; Neil K Aaronson
Journal:  Eur J Cancer       Date:  2008-09-05       Impact factor: 9.162

  4 in total
  2 in total

1.  The Prostate Cancer Outcomes (PCO) study in prostate cancer centres certified by the German Cancer Society.

Authors:  Christoph Kowalski; Günther Carl; Günter Feick; Simone Wesselmann
Journal:  Strahlenther Onkol       Date:  2020-06-16       Impact factor: 3.621

2.  The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.

Authors:  Martin H Umbehr; Lucas M Bachmann; Cedric Poyet; Peter Hammerer; Johann Steurer; Milo A Puhan; Anja Frei
Journal:  Health Qual Life Outcomes       Date:  2018-02-20       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.